Keywords : antibody, biosimilar, recombinant protein, protein
Summary Fusion Antibodies Ltd (Fusion) is a biotechnology company, based in Ireland. It develops therapeutic and fusion antibodies. The company provides contract services such as custom expression and purification of recombinant proteins, antibody cell line sequencing, antibody engineering, antibody humanization and biosimilar development and cGMP services. Fusion offers antibody characterization tools to help with antibody developm...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Summary
Fusion Antibodies Ltd (Fusion) is a biotechnology company, based in Ireland. It develops therapeutic and fusion antibodies. The company provides contract services such as custom expression and purification of recombinant proteins, antibody cell line sequencing, antibody engineering, antibody humanization and biosimilar development and cGMP services. Fusion offers antibody characterization tools to help with antibody development that includes endotoxin analysis, FACS analysis, SEC Analysis, IEF gel analysis, biacore analysis, ESI-MS, 15AA N-term sequencing and glycoform profiling – CE-LIF, RP-HPLC, SE-HPLC. Its investors include NiTech solutions, QUBIS, Crescentcapital and Clarendon Fund Managers. Fusion is headquartered in Belfast, Northern Ireland.
Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Biopharmaceutical Industry in Ireland
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 3
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 8
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Fusion Antibodies Secures $2.47 Million In Venture Financing Round 9
Partnerships 11
Selexis Enters Into Partnership Agreement With Fusion Antibodies 11
Antitope Enters Into Research Agreement With Fusion Antibodies 12
Licensing Agreements 13
Life Technologies Enters Into Licensing Agreement With Fusion Antibodies 13
Fusion Antibodies Ltd - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Tables
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Key Facts 1
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 1
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 1
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 1
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Fusion Antibodies Ltd, Deals By Therapy Area, 2007 to YTD 2013 7
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 8
Fusion Antibodies Secures $2.47 Million In Venture Financing Round 9
Selexis Enters Into Partnership Agreement With Fusion Antibodies 11
Antitope Enters Into Research Agreement With Fusion Antibodies 12
Life Technologies Enters Into Licensing Agreement With Fusion Antibodies 13
Fusion Antibodies Ltd, Key Competitors 14
Fusion Antibodies Ltd, Key Employees 15
List of Figures
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 1
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 5
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Fusion Antibodies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
